IRINA PRITCHARD: Open Payments
NPI 1144619909 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 124 payments from 28 companies in 2025. Trend: 2023 $1,709 · 2024 $2,133 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $700 |
| AstraZeneca Pharmaceuticals LP | 6 | $357 |
| Otsuka America Pharmaceutical, Inc. | 10 | $270 |
| Novo Nordisk Inc | 9 | $167 |
| Lundbeck LLC | 7 | $149 |
| PFIZER INC. | 9 | $136 |
| Ardelyx, Inc. | 5 | $106 |
| Amgen Inc. | 6 | $105 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Kowa Pharmaceuticals America, Inc. | 5 | $81 |
Products named: REXULTI, QULIPTA, UBRELVY, AIRSUPRA, VRAYLAR, BREZTRI, IBSRELA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
